Fresenius Kabi, part of the healthcare company Fresenius, and a leading provider of essential medicines and medical ...

U.S. Biological Buffers Market was Valued at USD 0.38 Billion in 2025 and is Expected to Reach USD 0.70 billion by 2033 Due to Rising Biologics and Vaccine DevelopmentAustin, Jan. 20, 2026 (GLOBE ...

During the 19th century, scientists found that the main constituents of different foods were carbohydrates, fats, proteins, ...

Cancer is a disease that starts with uncontrolled cell division and eventually causes tissue and organ damage. The disease may arise in any part of th.

Many biological processes are regulated by electricity—from nerve impulses to heartbeats to the movement of molecules in and out of cells. A study by Scripps Research scientists reveals a previously ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes COVID-19, uses a sophisticated tactic to evade the human body's defense ...

mRNA molecule, illustration. [Kateryna Kon/Science Photo Library/Getty Images] Messenger RNA (mRNA) has already transformed medicine, most notably through COVID‑19 vaccines that taught cells to act as ...

Scientists invented a new experimental system to study how age-related changes in egg cells make them more prone to chromosomal errors. When you purchase through links on our site, we may earn an ...

Ribosomes don’t just make proteins—they can sense when something’s wrong. When they collide, they send out stress signals that activate a molecule called ZAK. Researchers uncovered how ZAK recognizes ...

Toward the goal of elucidating endocrine system aging mechanisms, this study establishes the first single-cell aging atlas across multiple endocrine organs. The research reveals conserved aging ...

Airbus continues to work on key elements of a hydrogen fuel cell system for its ZEROe programme as it closes in on a critical technology milestone by year-end. Andy Reynolds, head of ZEROe hydrogen ...

Researchers at the University of Chicago have developed a modular cancer immunotherapy that can be switched on, off or reprogramed to attack different cancers. Promising initial testing results, ...